SCHEMBL13638422

SCHEMBL13638422

C=C1CC(Nc2nccc(-c3ccc(N4CCNCC4)s3)n2)CC(C)(C)N1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK9 P50750 10/20 0.40
CDK4 P11802 10/20 0.40
CCND1 P24385 10/20 0.40
CCNT1 O60563 9/20 0.40
CDK7 P50613 9/20 0.40
CDK2 P24941 9/20 0.40
CCND3 P30281 8/20 0.40
CDK6 Q00534 8/20 0.40
CCNH P51946 7/20 0.40
CCNA2 P20248 7/20 0.40
CDK1 P06493 6/20 0.40
CCNB1 P14635 6/20 0.40
IKBKB O14920 5/20 0.37
MAPK8 P45983 3/20 0.37
CCNA1 P78396 1/20 0.36
PBK Q96KB5 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
CHEK1 O14757 1/20 0.35
AURKA O14965 1/20 0.35
DAPK3 O43293 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13638423 0.90 CDK4 (0.37) CDK9CDK4CCND1CCNT1CDK7
SCHEMBL3470774 0.88 CDK9 (0.40) CDK9CDK4CCND1CCNT1CDK7
SCHEMBL13638421 0.85 DGAT1 (0.44) CDK9CDK4CCND1CCNT1CDK7
SCHEMBL13638286 0.83 ROCK2 (0.35) CDK4CCND1CDK2CCND3CDK6
SCHEMBL14612785 0.82 IKBKB (0.37) CDK4CCND1CDK7CDK2CCND3
SCHEMBL13638454 0.82 CDK4 (0.36) CDK9CDK4CCND1CCNT1CDK7
SCHEMBL13638302 0.81 IKBKB (0.46) CDK4CCND1CDK2CCNA2CDK1
SCHEMBL14612849 0.81 IKBKB (0.35) CDK4CCND1CDK2CCND3CDK6
SCHEMBL13638501 0.81 HDAC8 (0.41) CDK2CCNA2CDK1CCNB1CCNA1
SCHEMBL13638420 0.81 KDM4E (0.38) CDK4CCND1CDK2CCND3CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed